Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Palvella Therapeutics, Inc. (PVLA) Institutional Ownership & Insider Trading

197 institutions reported holding Palvella Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 66 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PVLAPalvella Therapeutics, Inc.Follow PVLA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.8B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

197 institutions held 97.8% of the shares. Across filers that reported both quarters, shares held changed +6.3%.

Increased+88New+32Decreased-39Closed-16

Largest moves, shares (millions)

Jennison Associates+0.3MT. Rowe Price Associates+0.2MBlackRock+0.2MBvf Inc/il-0.3MFirst Light Asset Management-0.2MArtisan Partners Limited…-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Dec 24+1.1Mar 25+0.8Jun 25+2.6Sep 25+1.1Dec 25+3.4Mar 26+0.8Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2619714+6.3%88323916
Mar 2618013+37.1%63562717
Dec 2513910+13.4%38483012
Sep 25999+44.3%2140188
Jun 25656+15.3%192692
Mar 25415+27.0%91547
Dec 24334—————

Palvella Therapeutics, Inc. — questions

Who owns Palvella Therapeutics, Inc. stock?
197 institutions reported Palvella Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: SUVRETTA CAPITAL MANAGEMENT, LLC (7.9%), JENNISON ASSOCIATES LLC (6.7%), BlackRock, Inc. (6.4%).
Are Palvella Therapeutics, Inc. insiders buying or selling?
66 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Palvella Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.